La Jolla Pharmaceutical Company Profile (NASDAQ:LJPC)

Analyst Ratings

Consensus Ratings for La Jolla Pharmaceutical (NASDAQ:LJPC) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $42.40 (149.41% upside)

Analysts' Ratings History for La Jolla Pharmaceutical (NASDAQ:LJPC)
Show:
DateFirmActionRatingPrice TargetActions
6/22/2016SunTrust Banks Inc.Initiated CoverageBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/24/2016Lake Street CapitalInitiated CoverageBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/9/2016Cowen and CompanyInitiated CoverageOutperform$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/19/2016Noble FinancialReiterated RatingBuy$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/8/2015Chardan CapitalBoost Price TargetBuy$60.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2015HC WainwrightLower Price TargetBuy$29.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015Oppenheimer Holdings Inc.Initiated CoverageOutperform$43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for La Jolla Pharmaceutical (NASDAQ:LJPC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/5/2016        
5/6/2016Q416($0.74)($0.96)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2015Q315($0.71)($0.70)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2015Q215($0.61)($0.70)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/16/2015Q414($0.37)($0.45)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2014Q314($0.31)($0.37)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/14/2014Q214($0.69)($0.63)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2014($0.91)($0.93)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/31/2014($0.24)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for La Jolla Pharmaceutical (NASDAQ:LJPC)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.95)($0.95)($0.95)
Q3 20161($0.95)($0.95)($0.95)
Q4 20161($0.81)($0.81)($0.81)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for La Jolla Pharmaceutical (NASDAQ:LJPC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for La Jolla Pharmaceutical (NASDAQ:LJPC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
3/4/2016Kevin C TangDirectorBuy20,000$19.85$397,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/1/2016George F TidmarshCEOBuy2,000$16.57$33,140.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/28/2015Lakhmir S ChawlaInsiderBuy485$27.75$13,458.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2015Kevin C TangDirectorBuy80,000$38.00$3,040,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2015Kevin C TangDirectorBuy170,000$27.11$4,608,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/26/2015Kevin C TangDirectorBuy110,000$23.58$2,593,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/24/2015Kevin C TangDirectorBuy220,000$22.23$4,890,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/23/2015Kevin C TangDirectorBuy53,836$22.27$1,198,927.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/22/2015Kevin C TangDirectorBuy77,850$21.41$1,666,768.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2015Kevin C TangDirectorBuy190,583$18.24$3,476,233.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2015George F TidmarshCEOBuy4,000$18.37$73,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Kevin C TangDirectorBuy232,343$12.84$2,983,284.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2014George F TidmarshCEOBuy4,000$11.38$45,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/26/2014George F TidmarshCEOBuy2,000$9.35$18,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/26/2014Kevin C TangDirectorBuy169,555$9.14$1,549,732.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/25/2014Kevin C TangDirectorBuy30,500$9.17$279,685.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/24/2014Kevin C TangDirectorBuy95,000$9.10$864,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2014George F TidmarshCEOBuy5,000$9.18$45,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/23/2014George F TidmarshCEOBuy19,000$10.50$199,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2014George TidmarshCEOBuy12,000$7.37$88,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2014George TidmarshCEOBuy8,000$9.53$76,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/7/2014George F TidmarshCEOBuy3,000$7.25$21,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for La Jolla Pharmaceutical (NASDAQ:LJPC)
DateHeadline
07/26/16 08:00 AMCan Shares Of La Jolla Pharmaceutical Company (NASDAQ:LJPC) Hit $80? - Investor Newswire
07/23/16 08:55 AMLa Jolla Pharmaceutical Company Therapeutics and Product Pipeline Review H1 2016
07/23/16 08:55 AMLa Jolla Pharmaceutical Company : Therapeutics strategies and Product Pipeline Review 2016
07/22/16 07:55 AMLa Jolla Pharmaceutical Company (NASDAQ:LJPC): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/21/16 11:06 AMLa Jolla Pharmaceutical Company Can't Burn Your Long Portfolio. Has Another Strong Session - Consumer Eagle
07/20/16 03:05 PMEarnings Focus and Crowd Sourced Sentiment Review for La Jolla Pharmaceutical Company (NASDAQ:LJPC) - TGP
07/20/16 03:05 PMIs $80 Price Target Attainable For La Jolla Pharmaceutical Company (NASDAQ:LJPC)? - Investor Newswire
07/20/16 03:05 PMEquity Roundup: Stock Performance Focus on La Jolla Pharmaceutical Company (NASDAQ:LJPC) - Press Telegraph
07/18/16 02:57 PMLa Jolla Pharmaceutical Co. – Value Analysis (NASDAQ:LJPC) : July 18, 2016 -
07/18/16 10:14 AMLa Jolla Pharmaceutical Company (LJPC) Updated Price Targets - FTSE News
07/18/16 10:14 AMAre Analysts Bullish La Jolla Pharmaceutical Company (NASDAQ:LJPC) After Last Week? - Consumer Eagle
07/16/16 04:38 PMShares Experiencing a Downtrend: La Jolla Pharmaceutical Co. (NASDAQ:LJPC) - TGP
07/16/16 04:38 PMShares Moving Down on the Week: La Jolla Pharmaceutical Co. (NASDAQ:LJPC) - Engelwood Daily
07/16/16 04:38 PMTang Capital Management LLC Increased La Jolla Pharmaceutical Co (NASDAQ:LJPC) by $3.60 Million as Shares ... - Consumer Eagle
07/15/16 09:10 AMLa Jolla Pharmaceutical Company (NASDAQ:LJPC) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/14/16 05:11 PMBroker Outlook For La Jolla Pharmaceutical Company (LJPC) - Fiscal Standard
07/14/16 08:34 AMAnalyst Target and Average Rating Watch: La Jolla Pharmaceutical Company (NASDAQ:LJPC) - Press Telegraph
07/14/16 08:34 AMInsiders Increasing Positions in: La Jolla Pharmaceutical Co. (NASDAQ:LJPC) - Press Telegraph
07/12/16 09:21 AMLa Jolla Pharmaceutical Company (NASDAQ:LJPC) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/11/16 04:59 PMWere Analysts Bearish La Jolla Pharmaceutical Company (NASDAQ:LJPC) This Week? - Press Telegraph
07/11/16 04:59 PMStrong Sell Calls For La Jolla Pharmaceutical Company (NASDAQ:LJPC) At 0 - Investor Newswire
07/11/16 07:14 AMLa Jolla Pharmaceutical Co. breached its 50 day moving average in a Bullish Manner : LJPC-US : July 11, 2016 -
07/08/16 07:53 AMLa Jolla Pharmaceutical Company (LJPC) Current Analyst Ratings - Fiscal Standard
07/07/16 07:52 AMStock Tracking Down This Month; Investor Alert on La Jolla Pharmaceutical Co. (NASDAQ:LJPC) - Engelwood Daily
07/07/16 07:52 AMCompany Stock Focus for La Jolla Pharmaceutical Company (NASDAQ:LJPC): Which Way Will Shares Head? - Press Telegraph
07/06/16 09:38 AMNew Broker Ratings For La Jolla Pharmaceutical Company (LJPC) - FTSE News
07/02/16 07:50 AMRecently Issued Stock Ratings For La Jolla Pharmaceutical Company (LJPC) - Fiscal Standard
07/02/16 07:50 AMTang Capital Management LLC Increased La Jolla Pharmaceutical Co (NASDAQ:LJPC) by $3.60 Million as Shares ... - Press Telegraph
06/30/16 07:52 AMCovering the Bases on La Jolla Pharmaceutical Company (NASDAQ:LJPC): Where is the Stock Going? - Press Telegraph
06/29/16 04:51 PMLa Jolla Pharmaceutical Co. Stock Momentum at Critical Inflection Point - CML News
06/29/16 04:51 PMLa Jolla Pharmaceutical Company on Focus After Forming Multiple Bottom Chart Pattern - Press Telegraph
06/29/16 07:48 AMBroker Outlook For The Week Ahead La Jolla Pharmaceutical Company (LJPC) - Fiscal Standard
06/29/16 07:48 AMStrong Sell Calls Recommendations For La Jolla Pharmaceutical Company (NASDAQ:LJPC) At 0 - Investor Newswire
06/27/16 07:27 AMLa Jolla Pharmaceutical Co. breached its 50 day moving average in a Bearish Manner : LJPC-US : June 27, 2016 -
06/24/16 04:57 PMShare Volatility Check for: La Jolla Pharmaceutical Co. (NASDAQ:LJPC) - Press Telegraph
06/24/16 07:37 AMLa Jolla Pharmaceutical Company (NASDAQ:LJPC) Earnings Glance and Target Price Review - Engelwood Daily
06/22/16 03:02 PMAnalyst Update: T2 Biosystems Inc, La Jolla Pharmaceutical Company, and Illumina, Inc.
06/21/16 04:38 PMStrong Buy Calls Count For La Jolla Pharmaceutical Company (NASDAQ:LJPC) At 5 - Investor Newswire
06/20/16 07:09 AMLa Jolla Pharmaceutical Company (LJPC) Analyst Price Targets For The Coming Week - Fiscal Standard
06/17/16 07:06 AMLa Jolla Pharmaceutical Co. breached its 50 day moving average in a Bullish Manner : LJPC-US : June 17, 2016 -
06/06/16 04:52 PMLa Jolla Pharmaceutical Company to Provide Corporate Overview at the Jefferies 2016 Global Healthcare Conference - Business Wire (press release)
06/06/16 04:52 PMLA JOLLA PHARMACEUTICAL CO. (NASDAQ:LJPC) Financial Condition Compared to S&P 500 - CML News
06/06/16 07:18 AMLa Jolla Pharmaceutical Company to Provide Corporate Overview at the Jefferies 2016 Global Healthcare Conference - [at noodls] - SAN DIEGO-(BUSINESS WIRE)- La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients ...
06/04/16 07:44 AMLa Jolla Pharmaceutical Company (NASDAQ:LJPC) Stock Update & Estimates - Stock Tick Tock
06/01/16 05:23 PMBiotech Daily Digest: The Biotech Rally Continues; Another Small Cap Gets Bought Out; Icahn Targets Allergan - La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. The company ...
05/29/16 12:06 AMTang Capital Management LLC Increased La Jolla Pharmaceutical Co (NASDAQ:LJPC) by $3.60 Million as Shares ... - CCH Daily News - Tang Capital Management LLC Increased La Jolla Pharmaceutical Co (NASDAQ:LJPC) by $3.60 Million as Shares ...CCH Daily NewsKevin C. Tang increased its stake in La Jolla Pharmaceutical Co (NASDAQ:LJPC) by 6.27% based on its latest 2016Q1 regulatory filing with the SEC. Tang Capital Management Llc bought 180,000 shares as the company's stock declined 16.56% while stock ...La Jolla Pharmaceutical Company (LJPC) Updated Analyst CoverageRisers & FallersAre Analysts Bearish La Jolla Pharmaceutical Company (NASDAQ:LJPC) After Last Week?HNNall 3 news articles »
05/26/16 07:22 PMVenbio Select Advisor LLC Decreased Stake in La Jolla Pharmaceutical Co. (NASDAQ:LJPC) by $11.45 Million as ... - CCH Daily News - Venbio Select Advisor LLC Decreased Stake in La Jolla Pharmaceutical Co. (NASDAQ:LJPC) by $11.45 Million as ...CCH Daily NewsVenbio Select Advisor Llc decreased its stake in La Jolla Pharmaceutical Co. (NASDAQ:LJPC) by 73.01% based on its latest 2016Q1 regulatory filing with the SEC. Venbio Select Advisor Llc sold 572,527 shares as the company's stock declined 16.56% while ...and more »
05/25/16 06:57 PMInsiders Are Gradually Buying La Jolla Pharmaceutical Co. (NASDAQ:LJPC) - Wall Street Hints and News - Insiders Are Gradually Buying La Jolla Pharmaceutical Co. (NASDAQ:LJPC)Wall Street Hints and NewsAccording to the latest SEC filings, insiders at La Jolla Pharmaceutical Co. (NASDAQ:LJPC) have increased their position in the stock by 1.64% over the past 6 months. Insiders now own 7.80% of total outstanding shares. There are both legal and illegal ...and more »
05/24/16 07:41 AMCoverage initiated on La Jolla Pharm by Lake Street -
05/18/16 07:03 PMRevenue Update on La Jolla Pharmaceutical Company(NASDAQ:LJPC) - Trade Calls - Revenue Update on La Jolla Pharmaceutical Company(NASDAQ:LJPC)Trade CallsLa Jolla Pharmaceutical Company(NASDAQ:LJPC) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during Pre-market on May 6, 2016. Company reported revenue of $234.00K. Analysts estimated a revenue of $210.00K.La Jolla Pharmaceutical Company (NASDAQ:LJPC) Reports Basic Consolidated EPS At $-2.6779Markets Dailyall 2 news articles »

Social

About La Jolla Pharmaceutical

La Jolla Pharmaceutical logoLa Jolla Pharmaceutical Company is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies to improve outcomes in patients suffering from life-threatening diseases. It is engaged in the research, development and commercialization of its technologies and drug candidates for pharmaceutical products. Its product candidates in development include LJPC-501, LJPC-401, LJPC-30Sa and LJPC-30Sb. The Company is developing LJPC-501 for the treatment of catecholamine-resistant hypotension (CRH). The Company is developing LJPC-401 for the treatment of iron overload, which occurs as a result of diseases, such as hereditary hemochromatosis, beta thalassemia, sickle cell disease and myelodysplastic syndrome. It is developing LJPC-30Sa and LJPC-30Sb not only for the treatment of serious bacterial infections but also for the potential treatment of rare genetic disorders, such as cystic fibrosis and Duchenne muscular dystrophy.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: LJPC
  • CUSIP:
Key Metrics:
  • Previous Close: $17.00
  • 50 Day Moving Average: $16.70
  • 200 Day Moving Average: $17.49
  • P/E Ratio: N/A
  • P/E Growth: -0.30
  • Market Cap: $310.32M
  • Beta: 1.85
  • Current Year EPS Consensus Estimate: $-3.99 EPS
  • Next Year EPS Consensus Estimate: $-3.86 EPS
Additional Links:
La Jolla Pharmaceutical (NASDAQ:LJPC) Chart for Friday, July, 29, 2016